Moreover, the ROC curve also demonstrated that SNRPD2, SNRPD3, and EIF4A3 could efficiently predict the metastasis in MM patients (SNRPD2, P < 0.01, AUC = 0.74; SNRPD3, P = 0.03, AUC = 0.65; EIF4A3, P = 0.07, AUC = 0.63; Figures 3(b)–3(d)). This evidence concerns the gene SNRPD2 and Miyoshi myopathy.